The contribution of pharmacogenetics to pharmacovigilance

Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting syste

“…In addition, real‐world data suggest that the application of pharmacogenetic tests to understand and prevent drug‐related complications could help clinicians identify patients with an increased risk of experiencing ADRs. As a result, the emerging field of “pharmacogenovigilance” seeks to address these unanswered questions by combining the expertise of both pharmacovigilance and pharmacogenetics …”

“…As a result, the emerging field of "pharmacogenovigilance" seeks to address these unanswered questions by combining the expertise of both pharmacovigilance and pharmacogenetics. 42,43…”